Menu Search
Equities

Fagron NV

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4A5:FRA

Fagron NV

Actions
  • Price (EUR)22.60
  • Today's Change-0.70 / -3.00%
  • Shares traded461.00
  • 1 Year change+13.45%
  • Beta0.4183
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. The Company specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. It operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.

  • Revenue in EUR (TTM)--
  • Net income in EUR--
  • Incorporated2007
  • Employees3.99k
  • Location
    Fagron NVVenecoweg 20ANAZARETH 9810BelgiumBEL
  • Phone+32 80012880
  • Fax+32 92162491
  • Websitehttps://fagron.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		FAGR:BRU since
announced		Transaction
value
Ricaro Importacao Industria e Comercio de Embalagens e Insumos LtdaAnnounced19 Dec 202519 Dec 2025Announced7.95%--
Amber Compounding Pharmacy Pte LtdAnnounced19 Dec 202519 Dec 2025Announced7.95%--
MagiLab KftDeal completed24 Nov 202524 Nov 2025Deal completed8.21%--
Zaklad Farmaceutyczny Amara Sp z o oDeal completed24 Nov 202524 Nov 2025Deal completed8.21%29.93m
University RX Specialists IncDeal completed25 Sep 202525 Sep 2025Deal completed14.29%41.50m
Data delayed at least 15 minutes, as of Feb 16 2026 16:35 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.